Opinion|Videos|March 14, 2025
How Bispecific Antibodies Are Reshaping Cancer Care
Experts discuss how the availability of bispecific therapies has influenced treatment paradigms in oncology and how bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How has the availability of bispecific therapies influenced treatment paradigms in oncology?
- How do bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
